Chair of Economic and Social Policy, WHU - Otto Beisheim School of Management, Burgplatz 2, 56179, Vallendar, Germany.
BMC Health Serv Res. 2022 Mar 26;22(1):398. doi: 10.1186/s12913-022-07769-x.
Artificial Intelligence (AI)-based assistance tools have the potential to improve the quality of healthcare when adopted by providers. This work attempts to elicit preferences and willingness to pay for these tools among German radiologists. The goal was to generate insights for tool providers and policymakers regarding the development and funding of ideally designed and priced tools. Ultimately, healthcare systems can only benefit from quality enhancing AI when provider adoption is considered.
Since there is no established market for AI-based assistance tools in radiology yet, a discrete choice experiment was conducted. Respondents from the two major German professional radiology associations chose between hypothetical tools composed of five attributes and a no-choice option. The attributes included: provider, application, quality impact, time savings and price. A conditional logit model was estimated identifying preferences for attribute levels, the no-choice option, and significant subject-related interaction effects.
114 respondents were included for analysis of which 46% were already using an AI-based assistance tool. Average adoption probability for an AI-based tool was 81% (95% CI 77.1% - 84.4%). Radiologists preferred a tool that assists in routine diagnostics performing at above-radiologist-level quality and saves 50% in diagnostics time at a price-point of €3 per study. The provider is not a significant factor in the decisions. Time savings were considered more important than quality improvements (i.e., detecting more anomalies).
Radiologists are overall willing to invest in AI-based assistance tools. Development, funding, and research regarding these tools should, however, consider providers' preferences for features of immediate everyday and economic relevance like time savings to optimize adoption.
人工智能 (AI) 辅助工具在被提供者采用时,具有提高医疗保健质量的潜力。本研究试图在德国放射科医生中征求对这些工具的偏好和支付意愿。目标是为工具提供商和政策制定者提供有关理想设计和定价工具的开发和资金的见解。最终,只有当考虑到提供者的采用时,医疗保健系统才能从提高质量的 AI 中受益。
由于放射科目前还没有建立 AI 辅助工具的市场,因此进行了离散选择实验。来自德国两个主要专业放射学协会的受访者在由五个属性和无选择选项组成的假设工具之间进行选择。这些属性包括:提供者、应用、质量影响、节省时间和价格。使用条件逻辑回归模型来识别属性水平、无选择选项和重要的与主题相关的交互作用的偏好。
共纳入 114 名受访者进行分析,其中 46%已经使用了基于 AI 的辅助工具。基于 AI 的工具的平均采用概率为 81%(95%CI 77.1% - 84.4%)。放射科医生更喜欢一种能够辅助常规诊断、达到高于放射科医生水平的质量并节省 50%诊断时间的工具,其价格为每例 3 欧元。提供者不是决策的重要因素。节省时间比提高质量(即检测更多异常)更重要。
放射科医生总体上愿意投资于基于 AI 的辅助工具。然而,这些工具的开发、资金和研究应该考虑提供者对即时日常和经济相关特征的偏好,例如节省时间,以优化采用。